Biodelivery sciences announces agreement to acquire u.s. and canadian rights to fda-approved elyxyb™ for the acute treatment of migraine

The only fda-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults

BDSI Ratings Summary

BDSI Quant Ranking